The case for more intensive use of statins

le Fulcher, Jordan, Keech, Anthony
Foilsithe 2012

Recruitment to randomised studies

le Hague, Wendy E, Gebski, Val J, Keech, Anthony C
Foilsithe in Med J Aust (2003)

An evaluation of the telehealth facilitation of diabetes and cardiovascular care in remote Australian Indigenous communities: - protocol for the telehealth eye and associated medic...

le Brazionis, Laima, Jenkins, Alicia, Keech, Anthony, Ryan, Chris, Bursell, Sven-Erik
Foilsithe in BMC Health Serv Res (2017)

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

le Bracken, Karen, Askie, Lisa, Keech, Anthony C, Hague, Wendy, Wittert, Gary
Foilsithe in BMJ Open (2019)

Shortening of telomere length by metabolic factors in diabetes: protective effects of fenofibrate

le Sutanto, Surya Shin Ichi, McLennan, Susan Virginia, Keech, Anthony C., Twigg, Stephen Morris
Foilsithe in J Cell Commun Signal (2019)

An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes

le Noonan, Jonathan E., Jenkins, Alicia J., Ma, Jian-Xing, Keech, Anthony C., Wang, Jie Jin, Lamoureux, Ecosse L.
Foilsithe 2013

Biomarkers in Diabetic Retinopathy

le Jenkins, Alicia J., Joglekar, Mugdha V., Hardikar, Anandwardhan A., Keech, Anthony C., O'Neal, David N., Januszewski, Andrzej S.
Foilsithe in Rev Diabet Stud (2015)

Associations with sight-threatening diabetic macular oedema among Indigenous adults with type 2 diabetes attending an Indigenous primary care clinic in remote Australia: a Centre o...

le Brazionis, Laima, Keech, Anthony, Ryan, Christopher, Brown, Alex, O'Neal, David, Boffa, John, Bursell, Sven-Erik, Jenkins, Alicia
Foilsithe in BMJ Open Ophthalmol (2021)

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models

le Chen, Ying, Hu, Yang, Lin, Mingkai, Jenkins, Alicia J., Keech, Anthony C., Mott, Robert, Lyons, Timothy J., Ma, Jian-xing
Foilsithe 2013

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

le Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Foilsithe 2009

Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials

le Gencer, Baris, Marston, Nicholas A, Im, KyungAh, Cannon, Christopher P, Sever, Peter, Keech, Anthony, Braunwald, Eugene, Giugliano, Robert P, Sabatine, Marc S
Foilsithe in Lancet (2020)

FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease

le Januszewski, Andrzej S., Watson, Chris J., O’Neill, Vikki, McDonald, Kenneth, Ledwidge, Mark, Robson, Tracy, Jenkins, Alicia J., Keech, Anthony C., McClements, Lana
Foilsithe in Sci Rep (2020)

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

le Rajamani, Kushwin, Colman, Peter G, Li, Li Ping, Best, James D, Voysey, Merryn, D'Emden, Michael C, Laakso, Markku, Baker, John R, Keech, Anthony C
Foilsithe 2009

A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials

le Simes, John, Voysey, Merryn, O'Connell, Rachel, Glasziou, Paul, Best, James D., Scott, Russell, Pardy, Christopher, Byth, Karen, Sullivan, David R., Ehnholm, Christian, Keech, Anthony
Foilsithe 2010

Correction: A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials

le Simes, John, Voysey, Merryn, O'Connell, Rachel, Glasziou, Paul, Best, James D., Scott, Russell, Pardy, Christopher, Byth, Karen, Sullivan, David R., Ehnholm, Christian, Keech, Anthony
Foilsithe 2010

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

le Best, James D., Drury, Paul L., Davis, Timothy M.E., Taskinen, Marja-Riitta, Kesäniemi, Y. Antero, Scott, Russell, Pardy, Christopher, Voysey, Merryn, Keech, Anthony C.
Foilsithe 2012

The Relationship between Endothelial Progenitor Cell Populations and Epicardial and Microvascular Coronary Disease—A Cellular, Angiographic and Physiologic Study

le Chan, Kim H., Simpson, Philippa J. L., Yong, Andy S., Dunn, Louise L., Chawantanpipat, Chirapan, Hsu, Chijen, Yu, Young, Keech, Anthony C., Celermajer, David S., Ng, Martin K. C.
Foilsithe 2014

Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina

le Ding, Lexi, Cheng, Rui, Hu, Yang, Takahashi, Yusuke, Jenkins, Alicia J., Keech, Anthony C., Humphries, Kenneth M., Gu, Xiaowu, Elliott, Michael H., Xia, Xiaobo, Ma, Jian-xing
Foilsithe 2014

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

le Fonarow, Gregg C., Keech, Anthony C., Pedersen, Terje R., Giugliano, Robert P., Sever, Peter S., Lindgren, Peter, van Hout, Ben, Villa, Guillermo, Qian, Yi, Somaratne, Ransi, Sabatine, Marc S.
Foilsithe in JAMA Cardiol (2017)

Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data

le Qamar, Arman, Giugliano, Robert P., Keech, Anthony C., Kuder, Julia F., Murphy, Sabina A., Kurtz, Christopher E., Wasserman, Scott M., Sever, Peter S., Pedersen, Terje R., Sabatine, Marc S.
Foilsithe in JAMA Cardiol (2018)